Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma

NCT01290692 is registered in ClinicalTrials.gov with TVAX Biomedical as lead sponsor.

NCT NCT01290692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01290692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Lead sponsor
TVAX Biomedical
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2011
Completion date
February 28, 2014
Enrollment
14 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme, grade iv astrocytoma, grade iv glioma